-
Article | 2020.10.14
Covid-19: vaccine against SARS-CoV-2 infection, using the measles vector
Phase I testing in humans for the Institut Pasteur's SARS-CoV-2 vaccine candidate using the measles vector was lauchned in August 2020 in France and Belgium. Following the intermediate results of the Phase I clinical trial, the Institut Pasteur is stopping (January, 2021) development of the vaccine candidate based on the measles platform.
-
Report | 2020.04.03
Coronavirus SARS-CoV-2: A look back at three months of mobilisation against an emerging disease (COVID-19)
On December 31, 2019, the WHO China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. It was the official beginning of an epidemic that would rapidly become worldwide. In January, a task force was put in place at the Institut Pasteur and research projects were quickly launched. Here is a look back at three...
-
Article | 2020.06.22
Investigation of the first cases of coronavirus (COVID-19) infections and their contacts in Antananarivo, Madagascar
Aim: This study aims to understand the epidemiologic, clinical, virologic and immunologic characteristics of first infected cases, their evolution and household transmission. It is intended to follow confirmed infected cases and their household members. It will be conducted with clinicians from three hospital centers of Antananarivo.
-
Article | 2020.07.07
LuLISA project, bioluminescence as a tool for human diagnostics, from allergy to Covid19
LuLISA project, bioluminescence as a tool for human diagnostics, from allergy to Covid19
-
Article | 2020.07.07
CEPI collaborates with the Institut Pasteur in a consortium to develop Covid-19 vaccine
CEPI collaborates with the Institut Pasteur in a consortium to develop Covid-19 vaccine
-
Article | 2020.07.07
COVID-19: mathematical model indicates that between 3% and 7% of French people have been infected
COVID-19: mathematical model indicates that between 3% and 7% of French people have been infected
-
Article | 2021.09.24
Program analyzing the spread of the SARS-CoV-2 virus in high and low incidence areas of COVID-19 in Senegal
Thanks to the support provided by the Fondation SUEZ, sero-epidemiological studies were launched by the Dakar Pasteur Institute in July 2020, as part of the fight against the SARS-CoV-19 pandemic. Thesse comparative studies on the prevalence of anti-SARS-COV-2 antibodies were conducted to better identify the risk factors associated with the spread of SARS-CoV-2 virus in populations resideing in...
-
News | 2022.02.23
What is long COVID ?
In May 2020, while the first wave of the COVID-19 outbreak was coming to an end in France, initial reports emerged of patients with some persistent symptoms several weeks or months post-infection. This phenomenon, now referred to as "long COVID" (or post-COVID-19 syndrome) affects over 20% of patients after 5 weeks and over 10% of patients after 3 months. Serious or severe forms of initial SARS-...
-
News | 2024.12.09
Lessons learned from the COVID-19 crisis: improving protection through early response, rapid tracking and impact monitoring
Scientific experts from 13 Western European countries have recently completed a review of key lessons learned from the way the COVID-19 pandemic was handled. Two key findings have emerged. Firstly, death rates were lower in countries that took measures early. Secondly, the need for a surveillance system capable of quickly tracking the community spread of a virus and its impact on hospitals was...
-
News | 2022.02.01
CoronaFISH: a new method for studying SARS-CoV-2 and detecting its presence in the body
The COVID-19 pandemic, which has afflicted the world for more than two years, is caused by SARS-CoV-2. The genome of this respiratory virus is composed of a single strand of RNA, a molecule similar to DNA that enables the virus to replicate in the body. Scientists from the Institut Pasteur, Inserm and the Paris Public Hospital Network (AP-HP) have developed a new method, CoronaFISH, to observe...
